Farshad Fani Marvasti, MD | |
1776 North Scottsdale Road, #8468, Scottsdale, AZ 85252-8468 | |
(650) 924-5150 | |
Not Available |
Full Name | Farshad Fani Marvasti |
---|---|
Gender | Male |
Speciality | Family Medicine |
Location | 1776 North Scottsdale Road, Scottsdale, Arizona |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073846762 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | A109454 (California) | Primary |
207Q00000X | Family Medicine | 48330 (Arizona) | Secondary |
Entity Name | Honorhealth Medical Group, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043851793 PECOS PAC ID: 1557274057 Enrollment ID: O20031119000717 |
News Archive
Parkinson's disease (PD) is expected to reach over 14 million cases worldwide by 2040. As longevity increases, so does the number of persons living with PD.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has entered into settlement and license agreements with Wyeth, now part of Pfizer, relating to Venlafaxine Hydrochloride (HCl) Extended Release (ER) Capsules, 37.5 mg, 75 mg and 150 mg, the generic version of Wyeth's Effexor XR® Capsules, a treatment for major depressive disorder.
Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons' has opened up the path to femtomedicine, an entirely new cancer diagnostics, it was reported today at First Global Congress on NanoEngineering for Medicine and Biology in Houston, TX.
A new analysis reported in JAMA Psychiatry raises serious questions about the increasingly common use of second-generation antidepressant drugs to treat anxiety disorders.
› Verified 2 days ago
Entity Name | Wesley Community Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396910436 PECOS PAC ID: 9032264239 Enrollment ID: O20100407000432 |
News Archive
Parkinson's disease (PD) is expected to reach over 14 million cases worldwide by 2040. As longevity increases, so does the number of persons living with PD.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has entered into settlement and license agreements with Wyeth, now part of Pfizer, relating to Venlafaxine Hydrochloride (HCl) Extended Release (ER) Capsules, 37.5 mg, 75 mg and 150 mg, the generic version of Wyeth's Effexor XR® Capsules, a treatment for major depressive disorder.
Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons' has opened up the path to femtomedicine, an entirely new cancer diagnostics, it was reported today at First Global Congress on NanoEngineering for Medicine and Biology in Houston, TX.
A new analysis reported in JAMA Psychiatry raises serious questions about the increasingly common use of second-generation antidepressant drugs to treat anxiety disorders.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Farshad Fani Marvasti, MD Po Box 8468, Scottsdale, AZ 85252-8468 Ph: () - | Farshad Fani Marvasti, MD 1776 North Scottsdale Road, #8468, Scottsdale, AZ 85252-8468 Ph: (650) 924-5150 |
News Archive
Parkinson's disease (PD) is expected to reach over 14 million cases worldwide by 2040. As longevity increases, so does the number of persons living with PD.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has entered into settlement and license agreements with Wyeth, now part of Pfizer, relating to Venlafaxine Hydrochloride (HCl) Extended Release (ER) Capsules, 37.5 mg, 75 mg and 150 mg, the generic version of Wyeth's Effexor XR® Capsules, a treatment for major depressive disorder.
Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons' has opened up the path to femtomedicine, an entirely new cancer diagnostics, it was reported today at First Global Congress on NanoEngineering for Medicine and Biology in Houston, TX.
A new analysis reported in JAMA Psychiatry raises serious questions about the increasingly common use of second-generation antidepressant drugs to treat anxiety disorders.
› Verified 2 days ago
Dr. Sam Saman Fereidouni, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7699 E Pinnacle Peak Rd, Suite 115, Scottsdale, AZ 85255 Phone: 480-300-4663 Fax: 480-300-4888 | |
Dr. Daniel Andrew Wool, ND Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 20801 N Scottsdale Rd Suite 205, Scottsdale, AZ 85255 Phone: 480-389-3265 | |
Helene Wechsler, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10900 N Scottsdale Rd, Suite 104, Scottsdale, AZ 85254 Phone: 480-990-1564 Fax: 480-990-3298 | |
Natasha Ryan, NMD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8412 E Shea Blvd, Suite 101, Scottsdale, AZ 85260 Phone: 480-874-1515 Fax: 480-991-8395 | |
Evan Scot Trost Ix, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8328 E. Hartford Dr., Scottsdale, AZ 85255 Phone: 480-214-9720 Fax: 480-214-9722 | |
Katayoun Baniriah, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 4845 E Thunderbird Rd, Scottsdale, AZ 85254 Phone: 480-699-7004 Fax: 480-699-6129 | |
Dr. Ronald Lewis Peters, MD, MPH Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13951 N Scottsdale Rd, Suite 100, Scottsdale, AZ 85254 Phone: 480-607-7999 Fax: 480-607-7998 |